Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 1Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Hepatocellular 6Liver Neoplasms 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Turcot syndrome 1Recurrence 1Rectal Neoplasms 1Pancreatic Neoplasms 1Meningioma 1Lung Neoplasms 1Liver Diseases 1Hepatocellular Carcinoma Non-resectable 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Endometrioid 1

Interventions

Early Intervention, Educational 30Educational Status 29Blood Specimen Collection 28Standard of Care 27Methods 25Exercise 20Magnetic Resonance Spectroscopy 19Radiosurgery 18Practice Guidelines as Topic 18Surveys and Questionnaires 17X-Rays 16Tomography, X-Ray Computed 13Radiotherapy 11Interviews as Topic 11Biopsy 11Specimen Handling 10Fluorodeoxyglucose F18 10Patient Navigation 9Bronchoscopy 9Thoracic Surgery, Video-Assisted 8Therapeutics 8Saline Solution 7Psychiatric Rehabilitation 7Palliative Care 7Control Groups 7Breathing Exercises 7Acupuncture Therapy 7Drug Therapy 6Cryosurgery 6Counseling 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lung Neoplasms × sintilimab × Clear all
NCT04973293 2024-11-19

Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer

Ruijin Hospital

Phase NA Recruiting
20 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡